Search

everythinglearnresearchcommunity

for

Search:↓

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

A child with low platelets and anemia was later found to have lupus.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Mother-in-law's tongue leaf extract at 20% concentration significantly promotes hair growth in male rabbits.

Visible and invisible changes on the face and hands can indicate heart problems, and manual hand stimulation can relieve chest pain.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Most cats with dermatophytosis had fungal infections, mainly caused by M. canis.

Most hair dye allergies are caused by para-phenylenediamine (PPD), and safer hair dye options are needed.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

People with HIV and low T cell counts have more hair and scalp problems.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

FUE hair transplants offer minimal scarring and are good for short hairstyles but are time-consuming and can be costly.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Hair test results can be misleading due to contamination, so they shouldn't be used alone to determine drug use.

PRP therapy safely improves hair growth in people with hair loss.

A new skin model from hair follicles is a safer, simpler alternative for skin tests.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.